Diabetes control is a constant obstacle for millions worldwide. Novel advancements in pharmaceutical research have brought forth two promising medications, tirzepatide and semaglutide, which hold the potential to revolutionize diabetes care. These medications, belonging to the more info class of glucagon-like peptide-1 (GLP-1) receptor agonists, o